Why Did Cathie Wood Buy AMD?
Noted tech investor Cathie Wood has used the recent stock…
Buy
52
TERN Quote, Financials, Valuation and Earnings
Last price:
$3.51
Seasonality move
:
-4.03%
Day range:
$3.37 - $3.62
52-week range:
$1.87 - $11.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.88x
Volume:
1.7M
Avg. volume:
1.3M
1-year change:
-33.84%
Market cap:
$305.5M
Revenue:
--
EPS (TTM):
-$1.13
Earnings Data
Next earnings date for TERN
May 13
2025
Most recent earnings per share
-$0.24
Beat by $0.06
(Mar 20/2025)
Consensus Estimate
-$0.30
(Mar 20/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TERN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$0.29 | -- |
| 05/13/2025 | Q1 | -- | -- | -- | -$0.27 | -- |
| 03/20/2025 | Q4 | -- | -- | -$0.24 | -$0.30 | $0.06 |
| 11/12/2024 | Q3 | -- | -- | -$0.28 | -$0.32 | $0.04 |
| 08/05/2024 | Q2 | -- | -- | -$0.31 | -$0.34 | $0.03 |
| 05/13/2024 | Q1 | -- | -- | -$0.30 | -$0.35 | $0.05 |
| 03/14/2024 | Q4 | -- | -- | -$0.29 | -$0.29 | $0.00 |
| 11/14/2023 | Q3 | -- | -- | -$0.42 | -$0.31 | -$0.11 |
| 08/08/2023 | Q2 | -- | -- | -$0.25 | -$0.33 | $0.08 |
| 05/15/2023 | Q1 | -- | -- | -$0.31 | -$0.27 | -$0.04 |
| 03/27/2023 | Q4 | -- | -- | -$0.29 | -- | -- |
| 11/09/2022 | Q3 | -- | -- | -$0.44 | -- | -- |
| 08/08/2022 | Q2 | -- | -- | -$0.55 | -- | -- |
| 05/16/2022 | Q1 | -- | -- | -$0.55 | -- | -- |
| 03/03/2022 | Q4 | -- | $1M | -$0.56 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$0.47 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$0.43 | -- | -- |
| 05/14/2021 | Q1 | -- | -- | -$0.88 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | $0.03 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.48 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.40 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.38 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.41 | -- | -- |
Terns Pharmaceuticals Earnings Questions
-
How Much did Terns Pharmaceuticals Generate in Revenue Last Quarter?
Terns Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Terns Pharmaceuticals Beat Earnings Last Quarter?
Terns Pharmaceuticals announced earnings per share of -$0.24 which represents a beat of analyst forecast a -$0.30 per share.
-
Is Terns Pharmaceuticals Profitable?
Terns Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Terns Pharmaceuticals EPS Next Year?
Terns Pharmaceuticals's earnings are forecast to decrease from -$1.12 per share to -$1.18 per share next year representing a decrease of -6.8%.
-
When is Terns Pharmaceuticals's Earnings Date?
Terns Pharmaceuticals's next earnings date is May 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Salesforce Stock Drop After a Strong Quarter?
Popular customer relationship management platform provider Salesforce (NYSE:CRM) has been…
Is Adobe Stock a Bargain With AI Tools Driving Growth?
The share price of American computer software company Adobe (NASDAQ:ADBE)…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
4
CABO alert for May 3
Cable One [CABO] is down 41.98% over the past day.
Buy
55
PDEX alert for May 3
Pro-Dex [PDEX] is down 32.02% over the past day.
Buy
91
TRUP alert for May 3
Trupanion [TRUP] is up 23.52% over the past day.
